Search

Your search keyword '"Lems SP"' showing total 33 results

Search Constraints

Start Over You searched for: Author "Lems SP" Remove constraint Author: "Lems SP"
33 results on '"Lems SP"'

Search Results

1. Successful lung transplantation in the presence of pre-existing donor-specific cytotoxic HLA Class II antibodies.

2. CCR5Δ32 genotype leads to a Th2 type directed immune response in ESRD patients.

3. Latent cytomegalovirus infection is an independent risk factor for late graft failure in renal transplant recipients.

4. Donor kidney adapts to body dimensions of recipient: no influence of donor gender on renal function after transplantation.

5. High plasma hemopexin activity is an independent risk factor for late graft failure in renal transplant recipients.

7. Copeptin, a surrogate marker of vasopressin, is associated with accelerated renal function decline in renal transplant recipients.

8. Pre-kidney-transplant blood transfusions do not improve transplantation outcome: a Dutch national study.

9. HLA-DR4, DR13(6) and the ancestral haplotype A1B8DR3 are associated with ANCA-associated vasculitis and Wegener's granulomatosis.

11. The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation.

12. HLA antigens and post renal transplant lymphoproliferative disease: HLA-B matching is critical.

13. Identification of three new DRB1 alleles, DRB1*0107, *0425 and *13012 and confirmation of DRB4*01033.

14. Identification of a new HLA-B*40 variant, B*4035.

15. Molecular and serological identification of the HLA-A*3404 allele.

16. Survival benefit of cardiopulmonary bypass support in bilateral lung transplantation for emphysema patients.

17. Identification of two new HLA-B22 variants, HLA-B*5509 and B*5606.

18. Rapid decreases in donor-specific cytotoxic T lymphocyte precursor frequencies and graft outcome after liver and lung transplantation.

19. Long-term outcome of lung transplantation is predicted by the number of HLA-DR mismatches.

20. Donor-specific hyporeactivity after liver transplantation: prominent decreases in donor-specific cytotoxic T lymphocyte precursor frequencies independent of changes in helper T lymphocyte precursor frequencies or suppressor cell activity.

21. Persistent unconjugated hyperbilirubinemia after liver transplantation due to an abnormal bilirubin UDP-glucuronosyltransferase gene promoter sequence in the donor.

22. Comparison of T cell responses in patients with a long-term surviving renal allograft versus a long-term surviving liver allograft. It's a different world.

23. Cytomegalovirus infection does not increase the risk of vanishing bile duct syndrome after liver transplantation.

24. Decreased frequency of HLA-DR13DR6 in Wegener's granulomatosis.

25. HLA type is not indicative for the effect of thymectomy in myasthenia gravis.

26. Flare-up of antigen-induced arthritis in mice after challenge with intravenous antigen: effects of pre-treatment with cobra venom factor and anti-lymphocyte serum.

27. Effects of IgG and IgM alloantibodies in the enhancement of mouse skin allografts and the relation with their opsonizing capacity in vivo.

28. Similar activities of IgG1 and IgG2 alloantibodies in enhancement of mouse skin grafts and in opsonization.

30. Effects of monoclonal anti-H-2Ld and anti-H-2Dd alloantibodies in the immunological enhancement of skin grafts and neonatal heart grafts in the mouse.

31. Immune regulation by monoclonal antibodies: failure to enhance mouse skin allografts.

32. Rejection of long-surviving mouse skin allografts after withdrawal of cyclosporin A therapy.

33. In vivo activity of an H-2 alloantiserum purified by affinity chromatography on transplantation antigens.

Catalog

Books, media, physical & digital resources